Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000515

Drug Information
Synonyms804-63-7; 909767-48-2; NSC131458; 864908-93-0; CID5317112; Quin-Release; IBS-L0034250; Quniacridine; MLS001335913; 767303-40-2; Chinine; FT-0082277; LS-141252; 898813-59-7; quinidina; 898814-28-3; CID6453100; Cin-Quin; AC1OCD62; 882741-47-1; CHEBI:15854; AC1L9AHW; NSC5362; AC1NSZYU; CID667449; I14-3397; SPBio_002379; AC1MI1Q5; GNF-Pf-180; AC1OCD5W; AC1NSV58; CID9967055; CID5484450; NSC 5362; CID5748152; D08458; CID5953; AC1MBNAI; CHEMBL21578; chininum; BIDD:GT0144; AC1NX8JM; CID637552; CID6857801; 888714-03-2; CID25522; AC1LDI43; Conchinin; TNP00086; Coccinine; CID5320867; CID10448938; Quinicardine; AC1LDI46; Quinine Dab; Kinidin; Quindine; Quinimax; Epiquinidine; AC1NSZYR; 6183-68-2; CCRIS 5755; 6151-40-2; 12239-42-8; Quinidex; CID3000825; 840482-04-4; MLS001335914; (-)-Quinine; CID1065; CID6604605; 900789-95-9; 909263-47-4; C20H24N2O2; SMR000718748; NSC192949; Kinidin (TN); KBio2_001392; NCI-C56246; 56-54-2; AC1Q4EZ5; 898814-00-1; LS-194958; AC1OFCPL; TCMDC-131239; AC1NUNMO; AC1NSV55; CID441073; 128544-03-6; SPBio_001375; Lopac-Q-1250; SB01652; AC1O56R7; AC1L3RNZ; DB00468; 22620_FLUKA; KBio2_006528; SMP1_000254; AB00514657; NSC667852; NCI60_004320; AC1MHWS7; LT00645788; ST056282; L001278; AC1L9AHT; MLS001304041; quinidine; CID2728270; HMS1607A11; IDI1_000134; 845886-64-8; LS-4562; KBio3_001551; 890027-24-4; AC1L1R7Y; 500225-45-6; KBio2_003960; CID6916036; 899813-83-3; CID5320868; DB00908; CID3032576; Coco-Quinine; AR-1H2065; GNF-PF-5459; Pitayine; AC1L199L; CID6916033; 883881-01-4; 130-89-2; HSDB 225; SMR000857275; BIB1110; Quinine; 6151-39-9; AC1Q4EZ6; KBio1_000134; BB_NC-0697; CHEMBL576997; 22600_FLUKA; 549-56-4; HMS1304I22; CID667448; D08460; CID3036746; Chinidin; 572-59-8; 21480-31-9; KST-1A1085; AC1OAH7Z; NSC 192949; Chinin; 1407-83-6; AR-1A4833; 72646-90-3; 910878-25-0; CHEMBL170; HSDB 2501; CID94175; GNF-Pf-5423; 909882-78-6; Novoquinidin; 11010-73-4; beta-Quinine; Quinora; LS-221; NINDS_000134; Q3625_SIGMA; chinidinum; 906550-97-8; 6119-70-6; HMS1989J09; 875538-34-4; 911445-75-5; 130-95-0; CHEMBL601807; CID8549; AC1MHDEF; Lopac-Q-0875; AC1L1ANE; quinina; 900786-66-5; bmse000511; AC1LCUGN; Conchinine; 894767-09-0; C06526; 910880-97-6; CHEBI:111177; CPD000857275; CID441074; 6591-63-5; Auriquin; C06527; AC1Q58AF; CID5317111; Pitayin; Quiniduran; Conquinine; AC1O7GNZ; 22620_SIGMA; Aflukin; HMS2089E05; 50-54-4; 55980-20-6; 6912-57-8; RH01857; CID7048767; Chinidine; LS-187236; I14-3348; SAM002264644; AC1NUNML; AC1O7EE0; 918778-04-8; CHEMBL97; Quindan; CID5484444; AC1MHUCH; 910899-51-3; OR28880; CHEBI:28593; CCRIS 672; CID6602154; AC1L1LHL; Q0006; 857212-53-4; CID3034034
IndicationVentricular arrhythmias
[ICD9: 427.1   ICD10: I47.2]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCOC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O    
Isomeric SMILESCOC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O
Therapeutic ClassAnti-Arrhythmia Agents
CAS NumberCAS 56-54-2
PubChem Compound IDCID 441074.
PubChem Substance IDSID 7980448.
SuperDrug ATC IDC01BA01
SuperDrug CAS ID000056542;
TargetSodium channel protein type 5 subunit alphaBlocker[2]
Ref 1Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26. To Reference
Ref 2Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine. Pharmacol Biochem Behav. 1998 Feb;59(2):305-12. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543